GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:12944413

From GONUTS
Jump to: navigation, search
Citation

Ozaslan, D, Wang, S, Ahmed, BA, Kocabas, AM, McCastlain, JC, Bene, A and Kilic, F (2003) Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J. Biol. Chem. 278:43991-4000

Abstract

The serotonin transporter (SERT) is an oligomeric glycoprotein with two sialic acid residues on each of two complex oligosaccharide molecules. In this study, we investigated the contribution of N-glycosyl modification to the structure and function of SERT in two model systems: wild-type SERT expressed in sialic acid-defective Lec4 Chinese hamster ovary (CHO) cells and a mutant form (after site-directed mutagenesis of Asn-208 and Asn-217 to Gln) of SERT, QQ, expressed in parental CHO cells. In both systems, SERT monomers required modification with both complex oligosaccharide residues to associate with each other and to function in homo-oligomeric forms. However, defects in sialylated N-glycans did not alter surface expression of the SERT protein. Furthermore, in heterologous (CHO and Lec4 cells) and endogenous (placental choriocarcinoma JAR cells) expression systems, we tested whether glycosyl modification also manipulates the hetero-oligomeric interactions of SERT, specifically with myosin IIA. SERT is phosphorylated by cGMP-dependent protein kinase G through interactions with anchoring proteins, and myosin is a protein kinase G-anchoring protein. A physical interaction between myosin and SERT was apparent; however, defects in sialylated N-glycans impaired association of SERT with myosin as well as the stimulation of the serotonin uptake function in the cGMP-dependent pathway. We propose that sialylated N-glycans provide a favorable conformation to SERT that allows the transporter to function most efficiently via its protein-protein interactions.

Links

PubMed PMC3042025 Online version:10.1074/jbc.M306360200

Keywords

Animals; CHO Cells; Carrier Proteins/chemistry; Carrier Proteins/genetics; Carrier Proteins/metabolism; Choriocarcinoma; Cricetinae; Cyclic GMP/pharmacology; Cyclic GMP-Dependent Protein Kinases/metabolism; Female; Gene Expression; Glycosylation; Macromolecular Substances; Membrane Glycoproteins/chemistry; Membrane Glycoproteins/genetics; Membrane Glycoproteins/metabolism; Membrane Transport Proteins; Mutagenesis, Site-Directed; N-Acetylneuraminic Acid/chemistry; N-Acetylneuraminic Acid/genetics; Nerve Tissue Proteins; Nonmuscle Myosin Type IIA/genetics; Nonmuscle Myosin Type IIA/metabolism; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/metabolism; Phosphorylation; Pregnancy; Protein Conformation; Rats; Serotonin/metabolism; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Uterine Neoplasms

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:SC6A4

enables

GO:0042803: protein homodimerization activity

ECO:0000315: mutant phenotype evidence used in manual assertion

F

Seeded From UniProt

complete

RAT:SC6A4

involved_in

GO:0051610: serotonin uptake

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete

RAT:SC6A4

enables

GO:0017022: myosin binding

ECO:0000353: physical interaction evidence used in manual assertion

UniProtKB:Q62812

F

Seeded From UniProt

complete

RAT:SC6A4

involved_in

GO:0051260: protein homooligomerization

ECO:0000314: direct assay evidence used in manual assertion

P

Seeded From UniProt

complete

See also

References

See Help:References for how to manage references in GONUTS.